Event Description
Topic
Exciting New Findings of Psychopharmacologic Treatments for PTSD
Presented By
Lori L. Davis, MD, clinical professor of psychiatry and behavioral neurobiology, The University of Alabama at Birmingham Heersink School of Medicine; associate chief of staff, Research and Development Service, VA Medical Center
Learning Objectives
- Describe pharmacologic targets for the treatment of post‐traumatic stress disorder ﴾PTSD﴿.
- Discuss findings of studies with new and older compounds in the treatment of PTSD.
- Describe the prevalence and economic burden of PTSD.
Accredidation Statement
Tower Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicans.
Accredidation Statement
Drexel University College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure
The course director and members of the planning committee do not have any relevant financial relationships with any commercial interests to disclose regarding today's presentation.
Faculty and all others who have ability to control the content of continuing medical education activities sponsored by Tower Health are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s). The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Lori L. Davis, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing,
selling, re‐selling, or distributing healthcare products used by or on patients:
Boehringer Ingelheim ‐ Consulting ‐ Relationship Has Not Ended
Otsuka ‐ Consulting ‐ Relationship Has Not Ended
Aptinyx ‐ Contracted Research ‐ Relationship Has Not Ended
Lori L. Davis, MD has indicated the presentation may include discussion of any off‐label uses of a product. Explanation Given: Lecture on recent
results of trials of medications for treatment of PTSD include off‐label uses of a drug. |
